These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 25463034
1. The opportunities of mining historical and collective data in drug discovery. Wassermann AM, Lounkine E, Davies JW, Glick M, Camargo LM. Drug Discov Today; 2015 Apr; 20(4):422-34. PubMed ID: 25463034 [Abstract] [Full Text] [Related]
2. Drug discovery FAQs: workflows for answering multidomain drug discovery questions. Chichester C, Digles D, Siebes R, Loizou A, Groth P, Harland L. Drug Discov Today; 2015 Apr; 20(4):399-405. PubMed ID: 25463038 [Abstract] [Full Text] [Related]
4. Active-learning strategies in computer-assisted drug discovery. Reker D, Schneider G. Drug Discov Today; 2015 Apr; 20(4):458-65. PubMed ID: 25499665 [Abstract] [Full Text] [Related]
5. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space. Koutsoukas A, Paricharak S, Galloway WR, Spring DR, Ijzerman AP, Glen RC, Marcus D, Bender A. J Chem Inf Model; 2014 Jan 27; 54(1):230-42. PubMed ID: 24289493 [Abstract] [Full Text] [Related]
6. A data mining method to facilitate SAR transfer. Wassermann AM, Bajorath J. J Chem Inf Model; 2011 Aug 22; 51(8):1857-66. PubMed ID: 21774471 [Abstract] [Full Text] [Related]
7. BioProfile--extract knowledge from corporate databases to assess cross-reactivities of compounds. Beck B. Bioorg Med Chem; 2012 Sep 15; 20(18):5428-35. PubMed ID: 22633121 [Abstract] [Full Text] [Related]
8. Exploring activity cliffs in medicinal chemistry. Stumpfe D, Bajorath J. J Med Chem; 2012 Apr 12; 55(7):2932-42. PubMed ID: 22236250 [No Abstract] [Full Text] [Related]
9. Project ranks billions of drug interactions. Reardon S. Nature; 2013 Nov 28; 503(7477):449-50. PubMed ID: 24284710 [No Abstract] [Full Text] [Related]
11. Graphs and networks in chemical and biological informatics: past, present and future. Sukumar N, Krein MP. Future Med Chem; 2012 Oct 28; 4(16):2039-47. PubMed ID: 23157237 [Abstract] [Full Text] [Related]
12. Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets. Clark AM, Dole K, Coulon-Spektor A, McNutt A, Grass G, Freundlich JS, Reynolds RC, Ekins S. J Chem Inf Model; 2015 Jun 22; 55(6):1231-45. PubMed ID: 25994950 [Abstract] [Full Text] [Related]
13. Expanding the medicinally relevant chemical space with compound libraries. López-Vallejo F, Giulianotti MA, Houghten RA, Medina-Franco JL. Drug Discov Today; 2012 Jul 22; 17(13-14):718-26. PubMed ID: 22515962 [Abstract] [Full Text] [Related]
14. Enhancing Molecular Promiscuity Evaluation Through Assay Profiles. Avram S, Curpan R, Bora A, Neanu C, Halip L. Pharm Res; 2018 Oct 18; 35(11):240. PubMed ID: 30338400 [Abstract] [Full Text] [Related]
15. Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence? Griffen EJ, Dossetter AG, Leach AG, Montague S. Drug Discov Today; 2018 Jul 18; 23(7):1373-1384. PubMed ID: 29577971 [Abstract] [Full Text] [Related]
16. Editorial: Descriptor Spaces for QSAR: Delving into the History of the Expanding Frontier. Basak SC, Mishra RK. Curr Comput Aided Drug Des; 2017 Jul 18; 13(1):4-7. PubMed ID: 28222673 [No Abstract] [Full Text] [Related]